Kymera Therapeutics, Inc. Common Stock

Go to Kymera Therapeutics, Inc. Common Stock Website

$42.97

-0.69 (-1.58%)
Live
Previous Close

$42.97

Day Range

$42.43 - $43.79

Previous Day Range

$42.57 - $43.84

Market Cap

$3.1 billion USD

Day Vol.

297531

Previous Day Vol.

379788

Currency

USD

Primary Exchange

Nasdaq

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' li...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Analysts are bullish on several little-known biopharma stocks, including Kymera Therapeutics, Vera Therapeutics, and Rapport Therapeutics, due to promising drug candidates and strong financial positions.

Related tickers: KYMR, VERA, RAPP.

Read Full Article

Several mid-cap stocks, including Applied Digital, Kymera Therapeutics, and Riot Platforms, saw significant gains last week due to various factors such as infrastructure deals, positive trial results, and increased bitcoin mining.

Related tickers: APLD, KYMR, RIOT.

Read Full Article
Trending Tickers

Please sign in to view